BlackRock Fund Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
GT
AAM
SCM
BIT
BlackRock Fund Advisors's EBS Position: Q4 2016 in Review
BlackRock Fund Advisors increased its Emergent Biosolutions (EBS) stake by 16% in Q4 2016, buying an estimated $11.2M and bringing the position to 2,663,371 shares worth $87.5M. The position accounts for 0.02% of the portfolio, ranked #1307.
BlackRock Fund Advisors first reported a position in EBS in Q2 2013 and has held it in 15 quarters since. 208 funds tracked by Wall St. Rank hold EBS as of Q4 2016.
- BlackRock Fund Advisors held 2,663,371 shares of Emergent Biosolutions worth $87.5M as of Q4 2016.
- BlackRock Fund Advisors bought 372,992 Emergent Biosolutions shares in Q4 2016, an estimated $11.2M.
- Emergent Biosolutions made up 0.02% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1307 holding.
- BlackRock Fund Advisors first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 15 quarters since.
- 208 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.